Book your free place at this event by ringing or emailing the Dana Centre.
Since the dawn of time humans have looked to nature to try and find cures for their aches and pains.
The Ancient Greeks would chew willow for pain relief, now it’s the main constituent of aspirin. Then during the 19th century the effects these compounds had on the body were studied and ways to refine and improve them were found by a new breed of scientists: pharmacologists.
Over the 20th century we saw the rise of the pharmaceutical industry, its blockbuster drugs beginning the conquest of pain and infection. But does Mother Nature still have more to give?
At the beginning of the 21st century we see the pharmaceutical industry at a time of change, retreat and restructuring: what will happen next? How close are we to the personalised medicines of the future that are matched to not only the disease but our individual genetic make-ups too?
How can the new wave of genetically modified ‘humanised’ mice improve the drug discovery process?
Speakers:
- Glenda Gillies, Imperial College London
- Chris John, Imperial College London
- Donal Singer, University of Warwick
- Steve Trimmel, Venomtech